Association Study of SLCO1B3 and ABCC3 Genetic Variants in Gallstone Disease

Genes (Basel). 2022 Mar 14;13(3):512. doi: 10.3390/genes13030512.

Abstract

There is growing evidence that gallstone formation may be genetically determined. Recent studies have shown that polymorphism of genes encoding proteins involved in bile acid transport may be associated with the risk of gallstone disease. The aim of this study was to investigate the association between SLCO1B3 (rs4149117:G>T, rs7311358:A>G) and ABCC3 (rs4793665:T>C, rs11568591:G>A) genetic variants and susceptibility to cholesterol gallstone disease, as well as gallstone composition. The study included 317 patients suffering from cholelithiasis who underwent cholecystostomy and 249 controls with no evidence of stones, confirmed by ultrasound examination. There were no statistically significant differences in the distribution of studied gene polymorphisms between patients with gallstone disease and healthy controls. No significant associations were observed between studied genotypes and the content of analyzed gallstone components: total cholesterol, bilirubin, CaCO3, nor the total bile acids. There was also no association between bile acid content in gallstones and the polymorphisms studied. The results of this study suggest that polymorphisms of SLCO1B3 and ABCC3 genes are not a valuable marker of gallstone disease susceptibility and do not influence gallstone composition.

Keywords: ABCC3; SLCO1B3; bile acids; gallbladder disease; genetic polymorphism.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bile Acids and Salts
  • Cholesterol
  • Gallstones* / genetics
  • Genotype
  • Humans
  • Multidrug Resistance-Associated Proteins* / genetics
  • Polymorphism, Genetic
  • Solute Carrier Organic Anion Transporter Family Member 1B3* / genetics

Substances

  • Bile Acids and Salts
  • Multidrug Resistance-Associated Proteins
  • SLCO1B3 protein, human
  • Solute Carrier Organic Anion Transporter Family Member 1B3
  • multidrug resistance-associated protein 3
  • Cholesterol